Some Confidence Is Lacking In NovoCure Limited (NASDAQ:NVCR) As Shares Slide 25%

Simply Wall StMar 1 07:07 ET

NovoCure Full Year 2024 Earnings: EPS Misses Expectations

Yahoo FinanceFeb 28 05:07 ET

Novocure Reports Strong 2024 Revenue Growth

TipRanksFeb 27 23:12 ET

NovoCure's Earnings Call: Growth Amid Challenges

TipRanksFeb 27 19:41 ET

Evercore Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $38

Moomoo NewsFeb 27 17:32 ET · Ratings

H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsFeb 27 12:31 ET · Ratings